Study reveals long term impact of childhood TBI
A new study has linked childhood TBI to higher anxiety [...]
MS drug slows disability progression, study shows
A major trial has found the MS drug ocrelizumab slowed [...]
Vermont bans herbicide over potential Parkinson’s link
Vermont has become the first US state to ban paraquat, [...]
Hospital to pilot test that ‘will save lives’
A rapid stroke test that can show whether a common [...]
‘Irreversible’ spinal cord damage may be reversed, research suggests
Spinal cord damage once thought irreversible may be reversible, after [...]
‘Voice of the Patient’ report captures lived reality of MS
A new report has highlighted urgent gaps in MS diagnosis, [...]
Robotic pianist paves way to new Parkinson’s therapies
US researchers have developed a robotic hand that can hear [...]
Italy probes Biogen over alleged attempt to block cheaper Sandoz MS drug
Italy’s competition watchdog has opened a probe into Biogen over [...]
CPotential extends partnership with Slater and Gordon
A charity which supports young people with movement disorders is [...]
ABILITY Neurotech gets approval to trial brain-computer interface in ALS patients
ABILITY Neurotech has announced it has received Investigational Medical Device [...]
